We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
A 34-year-old gravida 2, para 2 woman presents to the gynecology clinic for increasingly heavy menstrual bleeding over the past year. Periods occur every 28–29 days and are predictable. Bleeding lasts for seven days with the heaviest bleeding occurring on days 2 and 3. On those days, she uses super tampons and maxi pads, changing them every 2 hours, and at night is using night-time pads. She has to leave long meetings at work to change protection and has menstrual accidents. She passes large clots and describes “gushing” type bleeding when on the toilet. She has tried non-steroidal anti-inflammatory drugs and tranexamic acid for bleeding with only slight improvement in heaviness; oral contraceptive pills have not worked in the past and she is not using them now. She has no relevant past medical or surgical history and denies any drug allergy.
Septate uteri are the most prevalent congenital uterine anomaly in infertile women. Women with septate uteri have reduced conception rates and increased risks of first-trimester miscarriage, preterm birth and malpresentation at delivery. The prevalence of arcuate uteri in infertile women is almost identical to that of the general/fertile population. Acquired uterine abnormalities described in the chapter include endometrial polyps, intrauterine adhesions, and uterine fibroids. Hysteroscopic myomectomy is now considered the gold standard treatment for submucosal fibroids. Abdominal myomectomy remains the routine approach for most surgeons faced with multiple or large intramural fibroids. For appropriately trained surgeons, a laparoscopic approach may be adopted. Hysteroscopic resection of submucosal fibroids before IVF treatment is recommended. Although subfertile women who have otherwise asymptomatic fibroids may benefit from a myomectomy procedure, this approach should be individualised given the absence of any good randomised controlled trials (RCT) in this area.
This chapter gives a brief description of the physical principles and the applications of the most commonly used lasers in subfertility surgery. The most common application of laser in subfertility surgery is endometriosis. The role of extensive surgery to treat deeply infiltrating endometriosis is debatable with the exception of endometriomas where excision seems to be superior to ablation regarding spontaneous pregnancy rate. The Nd:YAG laser has been used successfully to treat intrauterine adhesions with encouraging reproductive outcomes. The Nd:YAG laser has been widely used for hysteroscopic myomectomies as one- or two-stage procedure. Interstitial myolysis using a bare optic fiber of KTP, YAG, or diode laser has been reported as resolving symptoms and leaving a uterus capable of child bearing. The KTP or the Nd: YAG is the laser of choice for uterine septums, and the CO2 laser is used for vaginal septums.
By
Caroline Overton, St. Michael's Hospital and the Bristol Royal Infirmary, Bristol, UK,
Colin Davis, Fertility Unit, St Bart's and the London Hospitals, London, UK
Fibroids are a frequent finding in women with infertility. Gonadotrophin releasing hormone agonists (GnRH-agonist) will cause both uterine and fibroid shrinkage and a reduction or elimination of menstrual flow. Uterine artery embolization offers an alternative method of treatment that allows conservation of the uterus. Under local anaesthesia and sedation, an 18-gauge needle can deliver heat to a fibroid with localized ablation of a fibroid. Hysteroscopic myomectomy may be considered for women with submucous fibroids less than 3 cm. Uterine septum is the most common congenital abnormality of the female reproductive tract with an incidence of 2-3% in the general population. This chapter discusses hydrosalpinx, endometriosis and ovulation induction, endometriosis and intrauterine insemination, endometriosis and in vitro fertilization, and management of ovarian cyst. It also explains elevated follicle stimulating hormone (FSH), thin endometrium, assisted reproductive techniques, and embryo transfer.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.